drugset / Trial / NCT00469586
Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe, Asia, North America and South America. The aim of this research trial is to compare the efficacy of inhaled insulin to glimepiride and metformin combination therapy in treatment of subjects with type 2 diabetes and to verify the safety of use (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects).
Timeline
- Start
- 2007-04-26
- Primary completion
- 2008-04-24
- Completion
- 2008-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 4 mg | Oral |
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | Metformin | Small molecule | 2000 mg | Oral |